Abstract
The action of various purified phospholipases on intact cells is reviewed, with special emphasis on platelets. Their effects are strongly dependent on the substrate specificity of the enzymes. Moreover, phospholipases can be divided into two groups according to their ability to hydrolyse phospholipids in an intact cell. Comparative studies of their behaviour towards phospholipid monolayers maintained at different surface pressures have allowed to estimate the surface pressure of erythrocyte and platelet membrane as 31–34 dynes/cm.
Non-lytic degradation of platelet phospholipids has been used to identify the phospholipids directly accessible on the platelet surface. An asymmetric distribution of phospholipids has been described for the membrane whose outer leaflet contains essentially choline-phospholipids, whereas the anionic procoagulant phospholipids (phosphatidylserine and phosphatidylinositol) are confined to the inner leaflet. Furthermore, as a consequence of phospholipid asymmetry, arachidonic acid is concentrated towards the inside of the platelets, since only 6% of the total cell content is present in the exterior half of the platelet membrane.
The platelet aggregation induced by exogenous phospholipase C is accompanied by phospholipid modifications such as phosphatidic and lysophosphatidic acid production. Since these changes occur also with physiological aggregating agents, some evidence is given for the involvement of endogenous platelet phospholipase C and diglyceride lipase, whose exact roles remain to be determined.
Similar content being viewed by others
References
A.J. Marcus, Adv. Lipid Res.4, 1–37 (1966).
R.F.A. Zwaal, Biochim. biophys. Acta515, 163–205 (1978).
A.J. Marcus J. Lipid Res.19, 793–826 (1978).
M. Hamberg, J. Svensson, T. Wakabayashi andB. Samuelsson, Proc. Natl. Acad. Sci. USA71, 345–349 (1974).
M. Hamberg andB. Samuelsson, Proc. Natl. Acad. Sci. USA71, 3824–3828 (1974).
M. Hamberg, J. Svensson andB. Samuelsson, Proc. Natl. Acad. Sci. USA72, 2994–2998 (1975).
S.R. Moncada, R. Gryglewski, S. Bunting andJ.R. Vane, Nature263, 663–665 (1976).
R.A. Johnson, D.R. Morton, J.H. Kinner, R.R. Gorman, J.C. McGuire, F.F. Sun, N. Whittaker, S. Bunting, J. Salmon, S. Monclada andJ.R. Vane, Prostaglandins12, 915–928 (1976).
W.E.M. Lands andB. Samuelsson, Biochim. Biophys. Acta164, 426–429 (1968).
H. Vonkeman andD.A. van Dorp, Biochim. Biophys. Acta164, 430–432 (1968).
I.K. Bills, J.B. Smith andM.J. Silver, Biochim. Biophys. Acta424, 303–314 (1976).
R.F.A. Zwaal, B. Roelofsen andC.M. Colley, Biochim. Biophys. Acta300, 178–193 (1973).
A.J. Verkleij, R.F.A. Zwaal, B. Roelofsen, P. Comfurius, D. Kastelijn andL.L.M. van Deenen, Biochim. Biophys. Acta323, 178–193 (1973).
R.F.A. Zwaal, B. Roelofsen, P. Comfurius andL.L.M. van Deenen, Biochim. Biophys. Acta406, 83–96 (1975).
H. Chap, J. Lloveras andL. Douste-Blazy, C. R. Acad. Sci. (Paris), Ser. D273, 1452–1455 (1971).
H. Chap andL. Douste-Blazy, Eur. J. Biochem.48, 351–355 (1974).
P.K. Schick andB.P. Yu, J. Clin. Invest.54, 1032–1039 (1974).
L.L.M. van Deenen andG.H. de Haas, Biochim. Biophys. Acta70, 538–553 (1963).
H. Ikezawa, M. Yamanegi, R. Taguchi, T. Miyashita andT. Ohyabu, Biochim. Biophys. Acta450, 154–164 (1976).
T. Wadstrom andR. Mollby, Biochim. Biophys. Acta242, 308–320 (1971).
R.A. Demel, W.S.M. Geurts van Kessel, R.F.A. Zwaal, B. Roelofsen, andL.L.M. van Deenen, Biochim. Biophys. Acta406, 97–107 (1975).
H. Chap, R.F.A. Zwaal andL.L.M. van Deenen, Biochim. Biophys. Acta467, 146–164 (1977).
B.B. Vargaftig, Y. Tranier andM. Chignard, Eur. J. Pharmacol.13, 19–29 (1975).
B. Perret, H. Chap andL. Douste-Blazy, Biochim. Biophys. Acta.
P.K. Schick, K.B. Kurica andG.K. Chacko, J. Clin. Invest.57, 1221–1226 (1976).
A.B. Otnaess andT. Holm, J. Clin. Invest.57, 1419–1425 (1976).
R.F.A. Zwaal, P. Comfurius andL.L.M. van Deenen, Nature268, 358–360 (1978).
H. Chap, G. Mauco, B. Perret, M.F. Simon andL. Douste-Blazy, Adv. Prostagl. Thromboxane Res.3, 97–104 (1978).
S.G. Iatridis, P.G. Iatridis, E. Tsiala-Paraschou S.G. Markidou andB.H. Ragatz, Haemostasis5, 165–175 (1976).
J.E. Vincent andF.J. Zijlstra, Prostaglandins12, 971–979 (1976).
H. Holmsen, H.J. Day andE. Storm, Biochim. Biophys. Acta186, 254–266 (1969).
G. Mauco, H. Chap, M.F. Simon andL. Douste-Blazy, Biochimie60, 653–661 (1978).
F.L. Call II andM. Rubert, J. Lipid Res.14, 466–474 (1973).
J.V. Lloyd, E.E. Nishizawa andJ.F. Mustard, Brit. J. Haematol.25, 77–99 (1973).
J.V. Lloyd andJ.F. Mustard, Brit. J. Haematol.26, 243–253 (1974).
E.G. Lapetina, K.A. Chandrabose andP. Cuatrecasas, Proc. Natl. Acad. Sci. USA75, 818–822 (1978).
G. Mauco, H. Chap andL. Douste-Blazy, FEBS Lett.100, 367–370 (1979).
R. Michell, Biochim. Biophys. Acta415, 81–147 (1975).
C.A. Tyson, H.V. Zande andD.E. Green, J. Biol. Chem.251, 1326–1332 (1976).
J.M. Gerrard, A.M. Butler, S.A. Peterson andJ.G. White, Prostaglandins Med.1, 387–396 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chap, H., Perret, B., Mauco, G. et al. Organization and role of platelet membrane phospholipids as studied with purified phospholipases. Agents and Actions 9, 400–406 (1979). https://doi.org/10.1007/BF01970668
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01970668